GreenLight Biosciences Holdings, PBC Warrant
GRNAW
GRNAW was delisted on the 21st of July, 2023.
21 hedge funds and large institutions have $6.83M invested in GreenLight Biosciences Holdings, PBC Warrant in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 6 closing their positions.
22% less funds holding
Funds holding: 27 → 21 (-6)
56% less capital invested
Capital invested by funds: $15.4M → $6.83M (-$8.56M)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$1.19M |
| 2 |
Morgan Stanley
New York
|
+$222 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$111K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$77K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$47.6K |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$44K |
| 5 |
HF
HRT Financial
New York
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| – | -$2.42K | -3,007 | -62% |
|
|
CS
27
Clear Street
New York
| – | -$2K | -2,625 | Closed |
|
|
28
Morgan Stanley
New York
| – | +$222 | +275 | +30% |
|
GRNAW Hedge Fund Activity: Q2 2022 in Review
21 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q2 2022, worth a combined $6.83M — down 56% from $15.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GRNAW and 0 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 2 added.
The largest buyer was LMR Partners, adding an estimated $1.19M. The largest seller was Aristeia Capital, cutting an estimated $111K.
- 21 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q2 2022, down from 27 in Q1 2022.
- Funds reported $6.83M of GreenLight Biosciences Holdings, PBC Warrant stock for Q2 2022, down 56% quarter-over-quarter.
- 0 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q2 2022 and 6 closed out, a net change of -6 holders.
- The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q2 2022 was LMR Partners, an estimated $1.19M added.
- The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q2 2022 was Aristeia Capital, an estimated $111K sold.
Based on aggregated 13F filings for Q2 2022.